Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation. Wood BR, Kassaye SG, Gerstoft J. AIDS 2023;37:689-691.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wood BR, Kassaye SG, Gerstoft J. Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation. AIDS 2023;37:689-691.
PMID: 36815522